Cohen Klingenstein’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16M | Hold |
124,194
| – | – | 0.46% | 29 |
|
|
2026
Q1 | $14.9M | Hold |
124,194
| – | – | 0.48% | 29 |
|
|
2025
Q4 | $13.1M | Hold |
124,194
| – | – | 0.4% | 33 |
|
|
2025
Q3 | $10.4M | Sell |
124,194
-3,041
| -2% | -$250K | 0.33% | 39 |
|
|
2025
Q2 | $10.1M | Sell |
127,235
-100
| -0.1% | -$7.95K | 0.34% | 39 |
|
|
2025
Q1 | $11.4M | Sell |
127,335
-7,001
| -5% | -$654K | 0.41% | 36 |
|
|
2024
Q4 | $13.4M | Sell |
134,336
-17,080
| -11% | -$1.76M | 0.46% | 29 |
|
|
2024
Q3 | $17.2M | Sell |
151,416
-164
| -0.1% | -$19.5K | 0.6% | 27 |
|
|
2024
Q2 | $18.8M | Hold |
151,580
| – | – | 0.68% | 23 |
|
|
2024
Q1 | $20M | Hold |
151,580
| – | – | 0.74% | 23 |
|
|
2023
Q4 | $16.5M | Sell |
151,580
-145
| -0.1% | -$15.1K | 0.68% | 25 |
|
|
2023
Q3 | $15.6M | Sell |
151,725
-207
| -0.1% | -$22.3K | 0.71% | 24 |
|
|
2023
Q2 | $17.5M | Sell |
151,932
-1,800
| -1% | -$204K | 0.76% | 24 |
|
|
2023
Q1 | $16.4M | Sell |
153,732
-1,045
| -0.7% | -$113K | 0.77% | 24 |
|
|
2022
Q4 | $17.2M | Sell |
154,777
-784
| -0.5% | -$80.1K | 0.86% | 21 |
|
|
2022
Q3 | $13.4M | Buy |
155,561
+1
| +0% | +$89 | 0.71% | 25 |
|
|
2022
Q2 | $14.2M | Sell |
155,560
-1,675
| -1% | -$148K | 0.71% | 26 |
|
|
2022
Q1 | $12.9M | Hold |
157,235
| – | – | 0.54% | 31 |
|
|
2021
Q4 | $12.1M | Sell |
157,235
-23,014
| -13% | -$1.83M | 0.48% | 37 |
|
|
2021
Q3 | $13.5M | Sell |
180,249
-24,677
| -12% | -$1.88M | 0.59% | 33 |
|
|
2021
Q2 | $15.9M | Sell |
204,926
-9,836
| -5% | -$732K | 0.69% | 31 |
|
|
2021
Q1 | $15.8M | Hold |
214,762
| – | – | 0.73% | 32 |
|
|
2020
Q4 | $16.8M | Hold |
214,762
| – | – | 0.84% | 30 |
|
|
2020
Q3 | $17M | Hold |
214,762
| – | – | 0.96% | 24 |
|
|
2020
Q2 | $15.8M | Hold |
214,762
| – | – | 0.97% | 23 |
|
|
2020
Q1 | $15.8M | Hold |
214,762
| – | – | 1.17% | 20 |
|
|
2019
Q4 | $18.6M | Hold |
214,762
| – | – | 1.08% | 20 |
|
|
2019
Q3 | $17.3M | Buy |
214,762
+24,104
| +13% | +$1.93M | 1.08% | 22 |
|
|
2019
Q2 | $15.3M | Sell |
190,658
-24,496
| -11% | -$1.88M | 1.09% | 22 |
|
|
2019
Q1 | $17.1M | Buy |
215,154
+123,480
| +135% | +$9.24M | 1.19% | 17 |
|
|
2018
Q4 | $6.68M | Hold |
91,674
| – | – | 1.01% | 19 |
|
|
2018
Q3 | $6.21M | Hold |
91,674
| – | – | 0.79% | 20 |
|
|
2018
Q2 | $5.31M | Hold |
91,674
| – | – | 0.73% | 23 |
|
|
2018
Q1 | $4.76M | Hold |
91,674
| – | – | 0.68% | 25 |
|
|
2017
Q4 | $4.92M | Hold |
91,674
| – | – | 0.7% | 27 |
|
|
2017
Q3 | $5.6M | Hold |
91,674
| – | – | 0.85% | 23 |
|
|
2017
Q2 | $5.61M | Hold |
91,674
| – | – | 0.87% | 23 |
|
|
2017
Q1 | $5.56M | Hold |
91,674
| – | – | 0.89% | 22 |
|
|
2016
Q4 | $5.15M | Hold |
91,674
| – | – | 0.88% | 21 |
|
|
2016
Q3 | $5.46M | Buy |
91,674
+16,768
| +22% | +$981K | 0.95% | 22 |
|
|
2016
Q2 | $4.12M | Hold |
74,906
| – | – | 0.76% | 25 |
|
|
2016
Q1 | $3.78M | Hold |
74,906
| – | – | 0.71% | 26 |
|
|
2015
Q4 | $3.77M | Hold |
74,906
| – | – | 0.7% | 25 |
|
|
2015
Q3 | $3.53M | Hold |
74,906
| – | – | 0.7% | 26 |
|
|
2015
Q2 | $4.07M | Hold |
74,906
| – | – | 0.73% | 29 |
|
|
2015
Q1 | $4.11M | Hold |
74,906
| – | – | 0.75% | 28 |
|
|
2014
Q4 | $4.06M | Hold |
74,906
| – | – | 0.76% | 26 |
|
|
2014
Q3 | $4.24M | Hold |
74,906
| – | – | 0.75% | 27 |
|
|
2014
Q2 | $4.13M | Hold |
74,906
| – | – | 0.79% | 25 |
|
|
2014
Q1 | $4.06M | Hold |
74,906
| – | – | 0.81% | 26 |
|
|
2013
Q4 | $3.58M | Sell |
74,906
-5,428
| -7% | -$248K | 0.71% | 26 |
|
|
2013
Q3 | $3.65M | Hold |
80,334
| – | – | 0.8% | 26 |
|
|
2013
Q2 | $3.56M | Buy |
+80,334
| New | +$3.59M | 0.83% | 26 |
|
Other funds holding MRK
ECSS
ATO
Cohen Klingenstein's MRK Position: Q2 2026 in Review
Cohen Klingenstein held its Merck (MRK) position steady in Q2 2026 at 124,194 shares worth $16M. The position accounts for 0.46% of the portfolio, ranked #29.
Cohen Klingenstein first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $20M in Q1 2024. 1,583 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cohen Klingenstein held 124,194 shares of Merck worth $16M as of Q2 2026.
- Cohen Klingenstein left its Merck share count unchanged in Q2 2026.
- Merck made up 0.46% of Cohen Klingenstein's portfolio in Q2 2026, its #29 holding.
- Cohen Klingenstein first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Cohen Klingenstein's Merck position peaked at $20M in Q1 2024.
- 1,583 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.